Top Industry Leaders in the Neuromodulation Devices Market
Latest Neuromodulation Devices Companies Update
December 2023, Medtronic, a global medical technology leader, acquired Nfocus Neuro, a pioneering company developing closed-loop deep brain stimulation (DBS) technology for
Parkinson's disease and other neurological disorders. This acquisition strengthens Medtronic's position in the neuromodulation market and paves the way for more personalized and effective DBS therapies.
Abbott, another major player in the market, launched its Proclaim Plus SCS System in September 2023. This advanced spinal cord stimulator features wireless recharge and MRI compatibility, offering greater convenience and flexibility for patients with chronic pain.
Boston Scientific received FDA approval in October 2023 for the use of its VNS Therapy System (vagus nerve stimulation) for treatment-resistant depression. This marks a significant milestone in the field of neuromodulation and offers new hope for patients struggling with this debilitating condition.
List of Neuromodulation Devices Key Companies in the Market
-
Nevro Corporation (U.S.)
-
LivaNova PLC (UK)
-
Boston Scientific Corporation (US)
-
Aleva Neurotherapeutics SA (US)
-
Bioness Inc. (US)
-
EnteroMedics Inc (US)
-
Neuronetics Inc. (US)
-
Cyberonics Inc. (US)
-
Jude Medical Inc. (U.S.)
-
Accellent (US)
-
DynaMD (US)